- Home
- DJT vs TMDX Comparison
DJT vs TMDX Comparison
Compare DJT & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DJT
- TMDX
- Stock Information
- Founded
- DJT 2021
- TMDX 1998
- Country
- DJT United States
- TMDX United States
- Employees
- DJT N/A
- TMDX N/A
- Industry
- DJT Computer Software: Programming Data Processing
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DJT Technology
- TMDX Health Care
- Exchange
- DJT Nasdaq
- TMDX Nasdaq
- Market Cap
- DJT 5.0B
- TMDX 4.8B
- IPO Year
- DJT N/A
- TMDX 2019
- Fundamental
- Price
- DJT $17.73
- TMDX $130.82
- Analyst Decision
- DJT
- TMDX Buy
- Analyst Count
- DJT 0
- TMDX 10
- Target Price
- DJT N/A
- TMDX $127.33
- AVG Volume (30 Days)
- DJT 9.1M
- TMDX 843.5K
- Earning Date
- DJT 08-08-2025
- TMDX 07-30-2025
- Dividend Yield
- DJT N/A
- TMDX N/A
- EPS Growth
- DJT N/A
- TMDX N/A
- EPS
- DJT N/A
- TMDX 1.41
- Revenue
- DJT $3,669,500.00
- TMDX $488,227,000.00
- Revenue This Year
- DJT N/A
- TMDX $34.07
- Revenue Next Year
- DJT N/A
- TMDX $20.76
- P/E Ratio
- DJT N/A
- TMDX $95.36
- Revenue Growth
- DJT N/A
- TMDX 64.43
- 52 Week Low
- DJT $11.75
- TMDX $55.00
- 52 Week High
- DJT $54.68
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- DJT 29.30
- TMDX 53.46
- Support Level
- DJT $17.49
- TMDX $120.36
- Resistance Level
- DJT $18.75
- TMDX $133.49
- Average True Range (ATR)
- DJT 0.88
- TMDX 5.52
- MACD
- DJT -0.13
- TMDX -2.21
- Stochastic Oscillator
- DJT 5.13
- TMDX 39.34
About DJT Trump Media & Technology Group Corp. Common Stock
Trump Media & Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest conversation without discriminating against political ideology.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.